Dyne Therapeutics

OverviewSuggest Edit

Dyne Therapeutics is a biotechnology company which offers targeted therapies for patients with cardiac diseases, and serious and smooth muscle diseases. The Company develops a program that will focus on using antibody-oligo conjugates to block the repetitive DNA mutations that cause the disease myotonic dystrophy type 1.

TypePrivate
Founded2018
HQWaltham, US
Websitedyne-tx.com

Latest Updates

Employees (est.) (Mar 2020)30(+4%)

Key People/Management at Dyne Therapeutics

Mo Qatanani

Mo Qatanani

Vice President, Discovery and Translational Research
Jonathan McNeill

Jonathan McNeill

Vice President, Business Development
Show more

Dyne Therapeutics Office Locations

Dyne Therapeutics has an office in Waltham
Waltham, US (HQ)
830 Winter St
Show all (1)

Dyne Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2018

Dyne Therapeutics total Funding

$50 m

Dyne Therapeutics latest funding size

$50 m

Time since last funding

a year ago

Dyne Therapeutics investors

Dyne Therapeutics's latest funding round in April 2019 was reported to be $50 m. In total, Dyne Therapeutics has raised $50 m
Show all financial metrics

Dyne Therapeutics Online and Social Media Presence

Embed Graph

Dyne Therapeutics Blogs

Dyne Therapeutics Announces Equity Investment from CureDuchenne Ventures to Support Pioneering Approach to Restoring Muscle Health in DMD

WALTHAM, Mass. –­­­ Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced an equity investment from CureDuchenne Ventures. The funding will support Dyne’s development of precision therapeutics designed to restore muscle he…

Dyne Therapeutics Expands Leadership Team with Key Hires

Appointments strengthen company’s capabilities across drug discovery, development and manufacturing WALTHAM, Mass. – Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the addition of three key members to its leadership…

Dyne Therapeutics Announces Appointment of Molly White as Vice President, Medical Communications and Advocacy

Former chief executive officer of Myotonic brings extensive experience in patient advocacy and community engagement WALTHAM, Mass.– Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the appointment of Molly White as Vi…

Dyne Therapeutics Announces Appointment of Joshua Brumm as President and Chief Executive Officer

Industry veteran brings extensive experience leading biotech companies through periods of growth WALTHAM, Mass.– Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the appointment of Joshua Brumm as President and Chief …

Dyne Therapeutics Announces Support for ReSolve Natural History Study of Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)

WALTHAM, Mass.– Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced its support for the ReSolve study, an ongoing natural history study designed to inform the development of therapies for facioscapulohumeral muscular dys…

Dyne Therapeutics Frequently Asked Questions

  • When was Dyne Therapeutics founded?

    Dyne Therapeutics was founded in 2018.

  • Who are Dyne Therapeutics key executives?

    Dyne Therapeutics's key executives are Mo Qatanani and Jonathan McNeill.

  • How many employees does Dyne Therapeutics have?

    Dyne Therapeutics has 30 employees.

  • Who are Dyne Therapeutics competitors?

    Competitors of Dyne Therapeutics include Ambrx, ProQR Therapeutics and Fulgent Genetics.

  • Where is Dyne Therapeutics headquarters?

    Dyne Therapeutics headquarters is located at 830 Winter St, Waltham.

  • Where are Dyne Therapeutics offices?

    Dyne Therapeutics has an office in Waltham.

  • How many offices does Dyne Therapeutics have?

    Dyne Therapeutics has 1 office.